#news #biotech Novavax shares in the red after vaccine sees 51% efficacy against South African COVID variant

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Novavax shares in the red after vaccine sees 51% efficacy against South African COVID variant .Novavax shares in the red after vaccine sees 51% efficacy against South African COVID variant
badams
Thu, 05/06/2021 – 03:52

from FierceBiotech: Biotech https://ift.tt/3nQkCvh